118 related articles for article (PubMed ID: 1348506)
1. Role of sulfhydryl groups in Y2 neuropeptide Y receptor binding activity.
Li W; MacDonald RG; Hexum TD
J Biol Chem; 1992 Apr; 267(11):7570-5. PubMed ID: 1348506
[TBL] [Abstract][Full Text] [Related]
2. Benextramine irreversibly inhibits [125I]neuropeptide Y affinity labeling of the Y2 binding protein in bovine hippocampus.
Li W; MacDonald RG; Hexum TD
Eur J Pharmacol; 1991 May; 207(1):89-91. PubMed ID: 1915595
[TBL] [Abstract][Full Text] [Related]
3. Cysteamine selectively enhances neuropeptide Y2 receptor binding activity.
Li W; Hexum TD
Biochem Biophys Res Commun; 1992 Apr; 184(1):380-6. PubMed ID: 1314592
[TBL] [Abstract][Full Text] [Related]
4. Nonpeptide peptidomimetic antagonists of the neuropeptide Y receptor: benextramine analogs with selectivity for the peripheral Y2 receptor.
Chaurasia C; Misse G; Tessel R; Doughty MB
J Med Chem; 1994 Jul; 37(14):2242-8. PubMed ID: 7913507
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y receptor in bovine hippocampus is a Y2 receptor.
Li W; MacDonald RG; Hexum TD
Life Sci; 1992; 50(10):695-703. PubMed ID: 1310789
[TBL] [Abstract][Full Text] [Related]
6. Benextramine-neuropeptide Y receptor interactions: contribution of the benzylic moieties to [3H]neuropeptide Y displacement activity.
Doughty MB; Chaurasia CS; Li K
J Med Chem; 1993 Jan; 36(2):272-9. PubMed ID: 8093737
[TBL] [Abstract][Full Text] [Related]
7. Failure of the putative neuropeptide Y antagonists, benextramine and PYX-2, to inhibit Y2 receptors in rat isolated prostatic vas deferens.
Palea S; Corsi M; Rimland JM; Trist DG; Ratti E
Br J Pharmacol; 1995 Nov; 116(5):2401-6. PubMed ID: 8581275
[TBL] [Abstract][Full Text] [Related]
8. Benextramine-neuropeptide Y (NPY) binding site interactions: characterization of 3H-NPY binding site heterogeneity in rat brain.
Doughty MB; Li K; Hu L; Chu SS; Tessel R
Neuropeptides; 1992 Nov; 23(3):169-80. PubMed ID: 1470308
[TBL] [Abstract][Full Text] [Related]
9. Characterization of neuropeptide Y (NPY) receptors in human hippocampus.
Li W; Hexum TD
Brain Res; 1991 Jul; 553(1):167-70. PubMed ID: 1657277
[TBL] [Abstract][Full Text] [Related]
10. Solubilization and affinity purification of the Y2 receptor for neuropeptide Y and peptide YY from rabbit kidney.
Sheikh SP; Hansen AP; Williams JA
J Biol Chem; 1991 Dec; 266(35):23959-66. PubMed ID: 1660889
[TBL] [Abstract][Full Text] [Related]
11. Binding profile of benextramine at neuropeptide Y receptor subtypes in rat brain areas.
Melchiorre C; Romualdi P; Bolognesi ML; Donatini A; Ferri S
Eur J Pharmacol; 1994 Nov; 265(1-2):93-8. PubMed ID: 7883034
[TBL] [Abstract][Full Text] [Related]
12. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
Tessel RE; Miller DW; Misse GA; Dong X; Doughty MB
J Pharmacol Exp Ther; 1993 Apr; 265(1):172-7. PubMed ID: 8474004
[TBL] [Abstract][Full Text] [Related]
13. Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed.
McAuley MA; Westfall TC
J Pharmacol Exp Ther; 1992 Jun; 261(3):863-8. PubMed ID: 1351098
[TBL] [Abstract][Full Text] [Related]
14. Purification and biochemical characterization of neuropeptide Y2 receptor.
Wimalawansa SJ
J Biol Chem; 1995 Aug; 270(31):18523-30. PubMed ID: 7629181
[TBL] [Abstract][Full Text] [Related]
15. Structural characterization of Y1 and Y2 receptors for neuropeptide Y and peptide YY by affinity cross-linking.
Sheikh SP; Williams JA
J Biol Chem; 1990 May; 265(14):8304-10. PubMed ID: 2159475
[TBL] [Abstract][Full Text] [Related]
16. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein.
Palea S; Corsi M; Rimland JM; Trist DG
Br J Pharmacol; 1995 May; 115(1):3-10. PubMed ID: 7647980
[TBL] [Abstract][Full Text] [Related]
17. Cross-linking of neuropeptide Y to its receptor on rat brain membranes.
Mannon PJ; Taylor IL; Kaiser LM; Nguyen TD
Am J Physiol; 1989 Mar; 256(3 Pt 1):G637-43. PubMed ID: 2538077
[TBL] [Abstract][Full Text] [Related]
18. Benextramine: a long-lasting neuropeptide Y receptor antagonist.
Doughty MB; Chu SS; Miller DW; Li K; Tessel RE
Eur J Pharmacol; 1990 Aug; 185(1):113-4. PubMed ID: 1977597
[No Abstract] [Full Text] [Related]
19. Ligand binding and functional effects of systematic double D-amino acid residue substituted neuropeptide Y analogs on Y1 and Y2 receptor types.
Grundemar L; Kahl U; Callréus T; Langel U; Bienert M; Beyermann M
Regul Pept; 1996 Apr; 62(2-3):131-6. PubMed ID: 8795076
[TBL] [Abstract][Full Text] [Related]
20. Chronic desipramine treatment reduces regional neuropeptide Y binding to Y2-type receptors in rat brain.
Widdowson PS; Halaris AE
Brain Res; 1991 Jan; 539(2):196-202. PubMed ID: 1647239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
